Advancing together and moving forward: Combination gene and cellular immunotherapies is a research paper published in Molecular Therapy — Oncolytics (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: R01 CA235667
NIH
Grant: R01 CA236615-01
NIH
Grant: P30 CA008748
NIH
Grant: P30 CA033572
NIH
Grant: P50 CA092131
California Institute for Regenerative Medicine
Grant: CLIN2-11574
DOD
Grant: CA180889
DOD
Grant: W81XWH1910758
DOD
Grant: LC160212
DOD
Grant: CA200437
DOD
Grant: BC132124
DOD
Grant: CA170630
DOD
Grant: W81XWH2110354
NCI NIH HHS
Grant: R01 CA236615
National Institutes of Health
Grant: 5P50CA092131-05
UCLA SPORE IN PROSTATE CANCER
National Institutes of Health
Grant: 5R01CA236615-02
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
National Institutes of Health
Grant: 5R01CA235667-02
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5P30CA033572-27
Developmental Funds
FWCI
0.28
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals